Xu Huipu, M.D., Professor of Medicine
Director of Department of Cardiology, Binzhou Medical Unversity Hospital
Director of Teaching and Research Office of Internal Medicine, the First School of Clinical Medicine
Director of Teaching and Research Office of Diagnostics, the First School of Clinical Medicine
Director of Diagnostics Laboratory, the First School of Clinical Medicine
Director of Department of Internal Medicine, Binzhou Medical Unversity Hospital
Research Fields
Prof. Xu has been engaged in clinical, teaching and scientific research in Cardiology for nearly 30 years. He specializes in the diagnosis and treatment of coronary heart disease, hypertension, arrhythmia, heart failure and other diseases and is good at clinical and research work of interventional cardiology.
Representative Research Papers
1. Research progress on the mechanism of inflammatory response of monomer C-reactive protein in acute coronary syndrome. Guo Wenbo. Xu Huipu *, Liu Changmei. Chinese Journal of Clinical Physicians. 2016, 10(16): 2457-2460.
2. Echocardiographic evaluation of left ventricular function before and after PCI in patients with acute coronary syndrome Greeny. Xu Huipu *, Liu Changmei. Clinical Cardiovascular Disease. 2015, (01): 19-22.
3. Effect of intracoronary tirofiban on platelet alpha-granule membrane protein and myocard-ial perfusion level during emergency percutaneous coronary intervention. XuHuipu*, C.M. Liu, W.W. Zhang. Genetics and Molecular Research. 2014, 13(4): 959-9605.
4. Comparison of efficacy and safety between bivalirudin and tirofibangabanheparin in emergency percutaneous coronary intervention. Xu Huipu*, Liu Changmei, China CirculationJournal. 2013, 28(6): 430-433.
5. Plaque Image Characteristics, Hyperhomocysteinemia, and Gene Polymorphism of Hom ocysteine Metabolism-Related Enzyme (MTHFR C677T) in Acute Coronary Syndrom. XuHuipu, Changmei Liu*, Qinghai Wang. Cell Biochemistry and Biophysics. 2013, 66 (2): 403-407.
6. Effects of tirofiban on platelet α -granular membrane protein and myocardial perfusion during emergency PCI. Xu Huipu*, Liu Changmei, Zhang Weiwei, Li Jingsen. Chinese Journal of Gerontology. 2013, 89 (15): 3569-3571.
7. Effect of bivalirudine on cardiac function in patients with emergency percutaneous coronary intervention. Xu Huipu*, Guo Wenbo. Chinese journal of gerontology. 2017, 37 (10): 2427-2430.
8. Association between monomer C-reactive protein, global area strain and short-term prognosis in STEMI patients undergoing emergency percutaneous coronary intervention. XuHuipu*, Shao Qiwen, Wang min. Chinese journal of gerontology. 2020, 40 (19): 4041-4044.
9. Research Progress on the correlation between galactose lectin 3 and pr ognosis of acut e coronary syndrome. Xu Huipu *, Wang Ning. Clinical Cardiovascular Disease. 2019, 35 (01): 88-91.
10. Correlation between mCRP, GAS and the degree of coronary artery disease in patients with acute ST-segment Elevation myocardial infarction. Xu Huipu *, Shao Qiwen, Liu Changmei. Journal of clinical cardiology. 2017,33(09) : 862-865
Research Projects
1. Shandong Natural Science Fund, The role of mCRP derived from phospholipase A2 mediated pentamer pCRP dissociation in the inflammatory response mechanism of acute coronary syndrome and related drug intervention research, 2014.12-2018.12.
2. Hehuang Pharmaceutical Fund, Effect of Shexiang Baoxin Pill on McRp-mediated Hedgehog in acute myocardial infarction, 2018.10-2021.10.
3. The international exchange of science foundation testing special fund of science and technology, vitK and myocardial infarction, correlation research, 2020.01-2023.01.
Academic Employment
Vice Chairman of Electrophysiology and Pace-making Branch of Shandong Provincial Medical Association;
Member of Cardiovascular Intervention Branch of Shandong Provincial Medical Association;
Vice Chairman of the Professional Committee of the Heart Rhythm of Shandong Medical Doctors Association;
Vice Chairman of Blood Study Group of Gestational Hypertension, Professional Committee of Hypertension of Shandong Medical Doctors Association;
Standing Committee Member of Cardiovascular Diseases Branch of Shandong Medical Doctors Association;
Vice Chairman of Professional Committee of Electrophysiology and Pace-making of Shandong Medical Doctors Association;
Standing Committee Member of Professional Committee of Stethalgia of Shandong Medical Doctors Association;
Vice Chairman of Professional Committee of the Heart Rhythm of Shandong Society of Biomedical Engineering;
Vice Chairman of Cardiovascular Diseases Branch of Shandong Non-government Medical Institutions Association;
Member of Shandong Provincial Cardiovascular Interventional Treatment Technology Quality Control Expert Committee;
Vice Chairman of Professional Committee of Cardiovascular Diseases of Binzhou Medical Association;
Vice Chairman of Professional Committee of Intervention of Binzhou Medical Association;
Vice Chairman of Professional Committee of Interventional Cardiology of Binzhou Medical Association;
Vice Chairman of Cardiology Intervention Quality Control Center of Binzhou Medical Association , etc.
